• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL LLC FIBEROPTIX ULTRA 8 IAB: 8FR 30CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL LLC FIBEROPTIX ULTRA 8 IAB: 8FR 30CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Catalog Number IAB-05830-LWS
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/29/2023
Event Type  malfunction  
Event Description
Reported as, "failed iab, rust specs observed in gas tubing".As a result, the iab was removed.A 2nd iab was not inserted as iabp therapy was no longer needed.No patient harm or injury.The patient status is reported as "fine".
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
Qn#(b)(4).The reported complaint for iab blood in helium pathway was confirmed upon the investigation of the returned sample.The customer returned a 30cc 8fr fiberoptix ultra intra-aortic balloon catheter (iabc) without the original packaging for investigation.The sample was returned in the supplied return kit and was in a sealed bio-hazard bag (inp-1, inp-2).Upon return, the distal end of the teflon sheath was at approximately 32.9cm from the iabc distal tip (inp-7).The one-way valve was noted tethered to the short driveline tubing (inp-5).The iabc bladder was fully unwrapped (inp-6).Bends to the iabc central lumen were noted at approximately 34.5cm and 53.1cm from the iabc distal tip (inp-8, inp-9).Dried blood was noted on the exterior surfaces of the returned sample.Dried blood was noted within the iabc helium pathway.The fos connector and cal key were examined.The fos gray connector was properly seated in the blue clamshell housing and both retaining tabs were intact (inp-10, inp-11, and inp-12).The center post of the fos was centered.The blue clamshell housing was examined, and no abnormalities were noted.The cal key was intact (inp-13, inp-14).The bladder thickness was measured at six points with measurements ranging from 0.0056in-0.0064in and was within specification of process document.The one-way valve was tested and passed.A vacuum was pulled on the one-way valve, and it held for at least 1 minute and then 30 seconds five separate times according to quality system document.The cal key and fos were connected to the iabp.The fos was recognized and zeroed by the iabp (anp-1, anp-2).The pump status displayed "ok" indicating the fiber is fully intact (anp-3).The catheter's central lumen was aspirated and flushed using a 60cc lab-inventory syringe.No abnormalities or debris were noted.The iabc was leak tested in accordance with testing methods from manufacturing procedure.A leak was immediately detected from the bladder membrane (anp-4).Under microscopic inspection, abrasions were observed from approximately 20.1cm to 20.8cm from the iabc distal tip (anp-5).A full thickness abrasion to the bladder was confirmed at approximately 20.4cm from the iabc distal tip and the appearance was consistent with repeated contact with calcified plaque on the aortic wall (anp-6).No other leaks were detected.A lab inventory 0.025in guidewire was back loaded through the iabc distal tip.The guidewire met resistance and could not advance at approximately 52.8cm from the iabc distal tip, which is the location of the previously noted bend.No blood was noted on the guidewire.The guidewire was front loaded through the iabc luer.The guidewire met resistance and could not advance at approximately 23.2cm from the iabc luer, which is the location of the previously noted bend.No blood was noted on the guidewire.Based on a review of the device history record (dhr), the product met specification upon release; however, the specifications were not met during the complaint investigation due to the bladder leak.The root cause of the bladder leak was related to patient condition.No further action required at this time.Teleflex will continue to monitor and trend for complaints of this nature.Other remarks: n/a corrected data: n/a.
 
Event Description
Reported as, "failed iab, rust specs observed in gas tubing".As a result, the iab was removed.A 2nd iab was not inserted as iabp therapy was no longer needed.No patient harm or injury.The patient status is reported as "fine".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FIBEROPTIX ULTRA 8 IAB: 8FR 30CC
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL LLC
morrisville NC
Manufacturer (Section G)
TELEFLEX MEDICAL
3015 carrington mill blvd
morrisville NC 27560
Manufacturer Contact
kevin don bosco
3015 carrington mill blvd
morrisville 27560
MDR Report Key18003698
MDR Text Key326488606
Report Number3011137372-2023-00236
Device Sequence Number1
Product Code DSP
UDI-Device Identifier00801902034724
UDI-Public00801902034724
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K021462
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/25/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2023
Device Catalogue NumberIAB-05830-LWS
Device Lot Number18F21L0024
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/23/2023
Is the Reporter a Health Professional? No
Date Manufacturer Received11/29/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/08/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age80 YR
Patient SexFemale
-
-